Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

OBJECTIVE: Beyond the joints, TNFi (tumour necrosis factor inhibitor) therapy may confer systemic benefits in rheumatoid arthritis (RA). Several studies have investigated the role of TNFi on insulin resistance/sensitivity (IR/IS). This question is of general interest given the emerging evidence link...

Descripción completa

Detalles Bibliográficos
Autores principales: Burska, Agata N., Sakthiswary, Rajalingham, Sattar, Naveed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482317/
https://www.ncbi.nlm.nih.gov/pubmed/26110878
http://dx.doi.org/10.1371/journal.pone.0128889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482317/
https://www.ncbi.nlm.nih.gov/pubmed/26110878
http://dx.doi.org/10.1371/journal.pone.0128889

Ejemplares similares